CheckupPoint AG – Trademark Portfolio
Entity Type: 25
CheckupPoint AG holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OCUMEDA.
Obere Mühle 8
CH-8586 Riedt bei Erlen
Showing of trademarks Trademarks
Trademark Classifications
CheckupPoint AG's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CheckupPoint AG have?
CheckupPoint AG has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does CheckupPoint AG file in?
CheckupPoint AG files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CheckupPoint AG's most well-known trademarks?
CheckupPoint AG's registered trademark portfolio includes well-known marks such as OCUMEDA. These are among 1 currently registered trademark in the portfolio.
What is CheckupPoint AG's trademark registration success rate?
CheckupPoint AG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.